MT
Mersana Therapeutics Inc
🇺🇸XNAS.MRSNUnited StatesHealthcare
$29.08USDdown -0.06 (-0.21%)OpenEnd of day6:51 PM
Price$29.08-0.06 (-0.21%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US59045L1061
- CUSIP
- 59045L106
Company
- Employees
- 102
- Headquarters
- Cambridge, United States
- Website
- https://www.mersana.com
- CEO
- Dr. Martin H. Huber M.D.
Market
- Shares outstanding
- 5M
- Market cap
- $145.36M
Highlights
No high and low reported for today's session.
- Market cap
- $145.36M
- EPS LTM
- -$14.02calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -2.07calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $33.18M-4.76%down year on year
- Net income
- -$70.08M+6.08%up year on year
- Gross margin
- 97.93%+104.02%up year on year
- Free cash flow
- -$74.37M+22.18%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.